Biosolution Co.Ltd Capital Reinvestment Ratio
Biosolution Co.Ltd capital reinvestment ratio. Biosolution Co.Ltd (086820) has a Capital Reinvestment Ratio of 1.27x as of September 2025, meaning it reinvests 1% of its operating cash flow (₩17.41 Million) in capital expenditures (₩22.15 Million). See how much free cash does Biosolution Co.Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Biosolution Co.Ltd (2018–2023)
Capital reinvestment ratio of Biosolution Co.Ltd from 2018 to 2023. This chart tracks Biosolution Co.Ltd's Capital Reinvestment Ratio across 3 annual periods. See Biosolution Co.Ltd (086820) flexibility index to measure the company's free cash flow as a share of total liabilities.
Biosolution Co.Ltd Capital Reinvestment Ratio by Year (2018–2023)
Biosolution Co.Ltd capital reinvestment ratio by year from 2018 to 2023. For the full cash flow conversion analysis, see 086820 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.54x | ₩2.16 Billion | ₩1.16 Billion | ▼ -93.3% |
| 2021 | 7.96x | ₩83.29 Million | ₩663.15 Million | ▲ +1054.8% |
| 2018 | 0.69x | ₩1.03 Billion | ₩707.50 Million | — |